Literature DB >> 8104417

Benzodiazepine dependence. Avoidance and withdrawal.

S Marriott1, P Tyrer.   

Abstract

Benzodiazepine dependence is a frequent complication of regular prescriptions for 4 weeks or longer, occurring in almost one-third of patients. Although it is also manifested by tolerance to drug effects and occasional drug seeking behaviour, particularly in those prone to drug abuse, most dependence is characterised by a withdrawal syndrome on stopping treatment. The withdrawal syndrome includes symptoms of anxiety and those of perceptual disturbance such as depersonalisation, hypersensitivity of all major senses, dysphoria and (rarely) epileptic seizures and psychotic episodes. Risk factors for dependence include high dosage, use of more potent and short acting benzodiazepines, long duration of therapy and dependent premorbid personality characteristics. If none of these apply, benzodiazepines can be prescribed with safety.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104417     DOI: 10.2165/00002018-199309020-00003

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  34 in total

1.  Withdrawal reaction after long-term therapeutic use of benzodiazepines.

Authors:  U Busto; E M Sellers; C A Naranjo; H Cappell; M Sanchez-Craig; K Sykora
Journal:  N Engl J Med       Date:  1986-10-02       Impact factor: 91.245

2.  The use of low-dose intranasal midazolam to treat panic disorder: a pilot study.

Authors:  E Schweizer; C Clary; A I Dever; L A Mandos
Journal:  J Clin Psychiatry       Date:  1992-01       Impact factor: 4.384

3.  Gradual withdrawal of diazepam after long-term therapy.

Authors:  P Tyrer; R Owen; S Dawling
Journal:  Lancet       Date:  1983-06-25       Impact factor: 79.321

4.  Benzodiazepine withdrawal: outcome in 50 patients.

Authors:  H Ashton
Journal:  Br J Addict       Date:  1987-06

5.  The general neurotic syndrome: a coaxial diagnosis of anxiety, depression and personality disorder.

Authors:  P Tyrer; N Seivewright; B Ferguson; J Tyrer
Journal:  Acta Psychiatr Scand       Date:  1992-03       Impact factor: 6.392

6.  The effect of minimal interventions by general practitioners on long-term benzodiazepine use.

Authors:  M A Cormack; R G Owens; M E Dewey
Journal:  J R Coll Gen Pract       Date:  1989-10

7.  Withdrawal from long-term benzodiazepine treatment.

Authors:  H Petursson; M H Lader
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-05

8.  Withdrawal symptoms from high dose benzodiazepines in poly drug users.

Authors:  N Seivewright; W Dougal
Journal:  Drug Alcohol Depend       Date:  1993-03       Impact factor: 4.492

Review 9.  Dependence as a limiting factor in the clinical use of minor tranquillizers.

Authors:  P Tyrer
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

Review 10.  High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.

Authors:  G E Tesar
Journal:  J Clin Psychiatry       Date:  1990-05       Impact factor: 4.384

View more
  10 in total

Review 1.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

2.  The impact of hospitalisation on the initiation and long-term use of benzodiazepines.

Authors:  Rutger Stuffken; Rolf P van Hulten; Eibert R Heerdink; Kris L L Movig; Antoine C G Egberts
Journal:  Eur J Clin Pharmacol       Date:  2005-05-14       Impact factor: 2.953

Review 3.  [Delirium in the context of intensive care medicine-Part 1: epidemiology, definitions, pathophysiology].

Authors:  R Haußmann; A Postler; M Mirus
Journal:  Nervenarzt       Date:  2022-10-21       Impact factor: 1.297

4.  Initiation of benzodiazepines in the elderly after hospitalization.

Authors:  Chaim M Bell; Hadas D Fischer; Sudeep S Gill; Brandon Zagorski; Kathy Sykora; Walter P Wodchis; Nathan Herrmann; Susan E Bronskill; Phil E Lee; Geoff M Anderson; Paula A Rochon
Journal:  J Gen Intern Med       Date:  2007-04-24       Impact factor: 5.128

5.  Pharmacoeconomic evaluation of a patient education letter aimed at reducing long-term prescribing of benzodiazepines.

Authors:  Julie D Morgan; David J Wright; Henry Chrystyn
Journal:  Pharm World Sci       Date:  2002-12

Review 6.  Guidelines for the rational use of benzodiazepines. When and what to use.

Authors:  H Ashton
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

7.  Current state of hypnotic use disorders: Results of a survey using the Japanese version of Benzodiazepine Dependence Self-Report Questionnaire.

Authors:  Mai Yamamoto; Ken Inada; Minori Enomoto; Mitsunari Habukawa; Takahisa Hirose; Yuichi Inoue; Jun Ishigooka; Yuichi Kamei; Tsuyoshi Kitajima; Masayuki Miyamoto; Hideto Shinno; Katsuji Nishimura; Motohiro Ozone; Masahiro Takeshima; Mayumi Suzuki; Hidehisa Yamashita; Kazuo Mishima
Journal:  Neuropsychopharmacol Rep       Date:  2020-12-01

Review 8.  Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review.

Authors:  André S Pollmann; Andrea L Murphy; Joel C Bergman; David M Gardner
Journal:  BMC Pharmacol Toxicol       Date:  2015-07-04       Impact factor: 2.483

9.  Benzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program.

Authors:  Julie L Cunningham; Julia R Craner; Michele M Evans; W Michael Hooten
Journal:  J Pain Res       Date:  2017-02-09       Impact factor: 3.133

10.  Lormetazepam addiction: data analysis from an Italian medical unit for addiction.

Authors:  Marco Faccini; Roberto Leone; Benedetta Pajusco; Gianluca Quaglio; Rebecca Casari; Anna Albiero; Monia Donati; Fabio Lugoboni
Journal:  Risk Manag Healthc Policy       Date:  2012-06-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.